Novel microsomal triglyceride transfer protein inhibitors

Author： Williams Spencer J   Best James D  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.4, 2003-04, pp. : 479-488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Lipid Modulating Drugs: The Role of Microsomal Transport Protein Inhibitors

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 943-949

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3150-3160

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite